Antimicrobial resistance patterns in outpatient urinary tractinfections - the constant need to revise prescribing habits

South African Medical Journal

Volumn 101, Issue 5, 2011, Pages 328-331

  Bosch, Fredricka J ^a   van Vuuren, Cloete ^a   Joubert, Gina ^a  

^a UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; CHILD; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NONHUMAN; OUTPATIENT; PRESCRIPTION; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SOUTH AFRICA; URINARY TRACT INFECTION; URINE CULTURE;

EID: 79957482508     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.4346     Document Type: Article

References (17)

1. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997;11(3):551-581.
2. Guneysel O, Onur O, Erdede M, Denizbasi A. Trimethoprim/sulfamethoxazole resistance in urinary tract infections. J Emerg Med 2009;36(4):338-341.
3. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 2002;8(113, suppl 1A): 14S-19S.
4. Gupta K. Addressing antibiotic resistance. Am J Med 2002;8(113, suppl 1A):29S-34S.
5. Miller LG, Tang AW. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance. Mayo Clin Proc 2004;79(8):1048-1053.
6. Sanford J P, Gilbert DN, Moellering Jr RC, Eliopoulos GM, Sande MA, Chambers HF. The Sanford Guide to Antimicrobial Therapy. 38th ed. Sperryville, VA, 2008: 27 (Table 1), 30.
7. Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of Infectious diseases. 6th ed. Philadelphia, Pa.: Elsevier Churchill Livingstone, 2005: 890.
8. Huovinen P. Resistance to TMP-SMX. Clin Infect Dis 2001;32:1608-1614.
9. Kallen AJ, Welch HG, Sirovich BE. Current antibiotic therapy for isolated urinary tract infections in women. Arch Intern Med 2006;166:635-639.
10. Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Med 2006;119(6):Suppl 1:S20-28, discussion S62-70.
11. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8(3):159-166.
12. Woodford N, Ward ME, Kaufmann ME, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2004;54(4):735-743.
13. Hillier S, Roberts Z, Dunstan F, Butler C, Howard A, Palmer S. Prior antibiotics and risk of antibioticresistant community-acquired urinary tract infection: a case-control study. J Antimicrob Chemother 2007;60(1):92-99.
14. Entenza JM, Que YA, Vouillamoz J, Glauser MP, Moreillon P. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Antimicrob Agents Chemother 2001;45(11):3076-3083.
15. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010; 340:c2096.
16. Alam MF, Cohen D, Butler C, et al. The additional costs of antibiotics and re-consultations for antibioticresistant Escherichia coli urinary tract infections managed in general practice. Int J Antimicrob Agents 2009;33(3):255-257.
17. Little P, Turner S, Rumsby K, et al. Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study. Health Technol Assess 2009;13(19):iii-iv, ix-xi, 1-73.